What is Eikon Therapeutics, Inc. 's total liabilities?

Eikon Therapeutics, Inc. (EIKN) reported total liabilities of $300.16M in Q1 2026.

What does total liabilities mean?

The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

MYR GroupMYRG

$970.61M-0.3%

UnifirstUNF

$617.11M+4.6%

HES

Hess MidstreamHESM

$3.94B+5.1%

Main Street CapitalMAIN

$2.73B+12.4%

Alkami Technology, Inc.ALKT

$458.69M-8.8%

GriffonGFF

$1.97B-7.4%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's total liabilities?: Eikon Therapeutics, Inc. (EIKN) reported total liabilities of $300.16M in Q1 2026.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.